Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.737,21
0,02%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Cantabio Pharmaceuticals Inc (CE) (CTBO) Cantabio Pharmaceuticals Inc (CE) (CTBO) Notizie

CTBO

Cantabio Pharmaceuticals (CE) (CTBO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:CTBO
DataOraFonteTitoloSimboloCompagnia
21/06/201922:12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/06/201922:09Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
21/06/201922:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
17/06/201920:20Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
24/05/201922:36Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/05/201923:39Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/04/201921:14Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
22/03/201919:25Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201823:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/10/201823:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/08/201816:09Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
16/07/201812:02Edgar (US Regulatory)Annual Report (10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
29/06/201816:54Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/08/201712:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
14/07/201717:15Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/05/201723:10Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
04/05/201712:10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
15/06/201613:00InvestorsHub NewsWireIndoor Harvest Corp (OTCQB: INQD) $25 million Sales Pipeline – $10 million ContractsUSOTC:CTBOCantabio Pharmaceuticals Inc (CE)
23/03/201621:42Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
20/07/201522:22Edgar (US Regulatory)Information Statement - Contested Solicitations (preliminary) (prec14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
16/07/201518:47Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:CTBO

La tua Cronologia

NASDAQ
OCSL
Oaktree Specialty Lending
BIT
W49M67
UBS
AMEX
IBID
ishares ibonds Oct 2027 ...
COIN
BULLSBTC
XE
VLNK
VanEck ETP
USOTC
MTSFY
Mitsui Fudosan (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network